G. Cragg, David Newman, K. Snader (1997)
Natural products in drug discovery and development.Journal of natural products, 60 1
Junxing Shi, G. Manolikakes, Chien‐Hung Yeh, C. Guerrero, R. Shenvi, Hiroki Shigehisa, P. Baran (2011)
Scalable synthesis of cortistatin A and related structures.Journal of the American Chemical Society, 133 20
S. Wrigley, Robert Thomas, N. Nicholson, C. Bedford (2010)
Functional molecules from natural sources
L. Costantino, D. Barlocco (2006)
Privileged Structures as Leads in Medicinal ChemistryCurrent Medicinal Chemistry, 13
A. Ganesan (2008)
The impact of natural products upon modern drug discovery.Current opinion in chemical biology, 12 3
A. Staniek, H. Woerdenbag, O. Kayser (2009)
Taxomyces andreanae: a presumed paclitaxel producer demystified?Planta medica, 75 15
Sivaraman Dandapani, L. Marcaurelle (2010)
Current strategies for diversity-oriented synthesis.Current opinion in chemical biology, 14 3
R. Breinbauer, I. Vetter, H. Waldmann (2002)
From protein domains to drug candidates – natural products as guiding principles inAngewandte Chemie, 41
Gustavo Moura-Letts, C. Diblasi, R. Bauer, Derek Tan (2011)
Solid-phase synthesis and chemical space analysis of a 190-membered alkaloid/terpenoid-like libraryProceedings of the National Academy of Sciences, 108
R. Macarron (2006)
Critical review of the role of HTS in drug discovery.Drug discovery today, 11 7-8
A. Graul, L. Revel, M. Barrionuevo, E. Cruces, E. Rosa, C. Vergés, B. Lupone, Nuria Diaz, R. Castañer (2009)
The year's new drugs & biologics - 2008.Drug news & perspectives, 22 1
J. Bok, D. Hoffmeister, L. Maggio-Hall, R. Murillo, J. Glasner, N. Keller (2006)
Genomic mining for Aspergillus natural products.Chemistry & biology, 13 1
V. Brinkmann, A. Billich, T. Baumruker, P. Heining, R. Schmouder, G. Francis, S. Aradhye, P. Burtin (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosisNature Reviews Drug Discovery, 9
Hans-Wilhelm Nützmann, Y. Reyes-Domínguez, K. Scherlach, V. Schroeckh, F. Horn, Agnieszka Gacek, Julia Schümann, C. Hertweck, J. Strauss, A. Brakhage (2011)
Bacteria-induced natural product formation in the fungus Aspergillus nidulans requires Saga/Ada-mediated histone acetylationProceedings of the National Academy of Sciences, 108
(1996)
Drug News Perspect
K. Vandermolen, W. McCulloch, C. Pearce, N. Oberlies (2011)
Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphomaThe Journal of Antibiotics, 64
Rebecca Wilson, S. Danishefsky (2006)
Applications of total synthesis to problems in neurodegeneration: Fascinating chemistry along the way.Accounts of chemical research, 39 8
R. Bai, T. Nguyen, J. Burnett, Onur Atasoylu, M. Munro, G. Pettit, Amos Smith, R. Gussio, E. Hamel (2011)
Interactions of Halichondrin B and Eribulin with TubulinJournal of chemical information and modeling, 51 6
A. Gunatilaka (2006)
Natural products from plant-associated microorganisms: distribution, structural diversity, bioactivity, and implications of their occurrence.Journal of natural products, 69 3
J. Audie, C. Boyd (2010)
The synergistic use of computation, chemistry and biology to discover novel peptide-based drugs: the time is right.Current pharmaceutical design, 16 5
D. Spring (2003)
Diversity-oriented synthesis; a challenge for synthetic chemists.Organic & biomolecular chemistry, 1 22
Timothy Newhouse, P. Baran, R. Hoffmann (2009)
The economies of synthesis.Chemical Society reviews, 38 11
O. Barun, S. Sommer, H. Waldmann (2004)
Asymmetric solid-phase synthesis of 6,6-spiroketals.Angewandte Chemie, 43 24
U. Grienke, M. Schmidtke, Susanne Grafenstein, J. Kirchmair, K. Liedl, J. Rollinger (2012)
Influenza neuraminidase: a druggable target for natural products.Natural product reports, 29 1
M. Marre, A. Penfornis (2011)
GLP-1 receptor agonists today.Diabetes research and clinical practice, 93 3
A. Graul, L. Sorbera, J. Bozzo, N. Serradell, L. Revel, J. Prous (2007)
The year's new drugs and biologics--2006.Drug news & perspectives, 20 1
J. Pérez, F. Corcho, O. Llorens (2002)
Molecular modeling in the design of peptidomimetics and peptide surrogates.Current medicinal chemistry, 9 24
Z. Gan, P. Reddy, S. Quevillon, S. Couve‐Bonnaire, P. Arya (2005)
Stereocontrolled solid-phase synthesis of a 90-membered library of indoline-alkaloid-like polycycles from an enantioenriched aminoindoline scaffold.Angewandte Chemie, 44 9
A. Buss (2009)
Natural product chemistry for drug discovery
R. Bade, Ho-Fung Chan, J. Reynisson (2010)
Characteristics of known drug space. Natural products, their derivatives and synthetic drugs.European journal of medicinal chemistry, 45 12
S. Giles, A. Soukup, C. Lauer, Mona Shaaban, Alexander Lin, B. Oakley, Clay Wang, N. Keller (2011)
Cryptic Aspergillus nidulans AntimicrobialsApplied and Environmental Microbiology, 77
R. Kumaran, B. Hur (2009)
Screening of species of the endophytic fungus Phomopsis for the production of the anticancer drug taxolBiotechnology and Applied Biochemistry, 54
Jennifer Smith, L. Wilson, O. Azarenko, Xiaojie Zhu, B. Lewis, B. Littlefield, M. Jordan (2010)
Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability.Biochemistry, 49 6
R. Spandl, M. Díaz-Gavilán, Kieron O'Connell, G. Thomas, D. Spring (2009)
Diversity-oriented synthesis.Chemical record, 8 3
H. Ueda, H. Nakajima, Y. Hori, T. Goto, M. Okuhara (1994)
Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells.Bioscience, biotechnology, and biochemistry, 58 9
R. Bauer, Jacqueline Wurst, Derek Tan (2010)
Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective.Current opinion in chemical biology, 14 3
D. Newman, G. Cragg (2007)
Natural products as sources of new drugs over the last 25 years.Journal of natural products, 70 3
A. Ganesan (2004)
Natural products as a hunting ground for combinatorial chemistry.Current opinion in biotechnology, 15 6
Laura Furst, C. Stephenson (2011)
Reaction design: Nature-inspired total synthesis.Nature chemical biology, 7 9
P. Meyers, C. Schwartz, M. Krailo, J. Healey, M. Bernstein, D. Betcher, W. Ferguson, M. Gebhardt, A. Goorin, M. Harris, E. Kleinerman, M. Link, H. Nadel, M. Nieder, G. Siegal, M. Weiner, R. Wells, R. Womer, H. Grier (2008)
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 4
J. Crawford, J. Clardy (2011)
Bacterial symbionts and natural products.Chemical communications, 47 27
M. Burke, S. Schreiber (2004)
A planning strategy for diversity-oriented synthesis.Angewandte Chemie, 43 1
Shun Su, Rodrigo Rodriguez, P. Baran (2011)
Scalable, stereocontrolled total syntheses of (±)-axinellamines A and B.Journal of the American Chemical Society, 133 35
H. Trenerry (2011)
Martindale: The complete drug reference. 37th ed.Australian Prescriber, 34
A. Graul, J. Prous, M. Barrionuevo, J. Bozzo, R. Castañer, E. Cruces, L. Revel, E. Rosa, N. Serradell, L. Sorbera (2008)
The year's new drugs and biologics--2007.Drug news & perspectives, 21 1
H. Wang (1999)
FR901228, Antineoplastic antibioticDrugs of The Future, 24
G. Carter (2011)
Natural products and Pharma 2011: strategic changes spur new opportunities.Natural product reports, 28 11
C. Cain, A. Doherty, A. Wood, J. Macor, M. Desai (2002)
Annual Reports in Medicinal Chemistry
J. Nielsen (2002)
Combinatorial synthesis of natural products.Current opinion in chemical biology, 6 3
J. Knäblein, F. Crick (2005)
Modern biopharmaceuticals : design, development and optimization
Shiying Shang, Derek Tan (2005)
Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries.Current opinion in chemical biology, 9 3
R. Macarron, M. Banks, D. Bojanic, David Burns, D. Cirovic, T. Garyantes, D. Green, R. Hertzberg, W. Janzen, J. Paslay, U. Schopfer, G. Sittampalam (2011)
Impact of high-throughput screening in biomedical researchNature Reviews Drug Discovery, 10
D. Newman (2008)
Natural products as leads to potential drugs: an old process or the new hope for drug discovery?Journal of medicinal chemistry, 51 9
H. Ueda, H. Nakajima, Y. Hori, T. Fujita, M. Nishimura, T. Goto, M. Okuhara (1994)
FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.The Journal of antibiotics, 47 3
I. Seiple, Shun Su, I. Young, A. Nakamura, Junichiro Yamaguchi, Lars Jørgensen, Rodrigo Rodriguez, Daniel O'Malley, T. Gaich, M. Köck, P. Baran (2011)
Enantioselective total syntheses of (-)-palau'amine, (-)-axinellamines, and (-)-massadines.Journal of the American Chemical Society, 133 37
Qi-Yin Chen, Yanxia Liu, H. Luesch (2011)
Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor ActivityACS Medicinal Chemistry Letters, 2
E. Jones, Antony Vinh, Claudia McCarthy, T. Gaspari, R. Widdop (2008)
AT2 receptors: Functional relevance in cardiovascular diseasePharmacology & Therapeutics, 120
J. Iwazawa, S. Ohue, K. Yasumasa, T. Mitani (2010)
Transarterial chemoembolization with miriplatin-lipiodol emulsion for neuroendocrine metastases of the liver.World journal of radiology, 2 12
R. Huijsduijnen, Agnès Bombrun, D. Swinnen (2002)
Selecting protein tyrosine phosphatases as drug targets.Drug discovery today, 7 19
H. Onaka, Y. Mori, Y. Igarashi, T. Furumai (2010)
Mycolic Acid-Containing Bacteria Induce Natural-Product Biosynthesis in Streptomyces SpeciesApplied and Environmental Microbiology, 77
V. Hruby (2009)
Organic chemistry and biology: chemical biology through the eyes of collaboration.The Journal of organic chemistry, 74 24
Peter Vanhee, A. Sloot, E. Verschueren, L. Serrano, F. Rousseau, J. Schymkowitz (2011)
Computational design of peptide ligands.Trends in biotechnology, 29 5
G. Soca-Chafre, F. Rivera-Orduña, M. Hidalgo-Lara, C. Hernández-Rodríguez, R. Marsch, L. Flores-Cotera (2011)
Molecular phylogeny and paclitaxel screening of fungal endophytes from Taxus globosa.Fungal biology, 115 2
H. Pelish, N. Westwood, Y. Feng, T. Kirchhausen, M. Shair (2001)
Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product.Journal of the American Chemical Society, 123 27
C. Lipinski (2004)
Lead- and drug-like compounds: the rule-of-five revolution.Drug discovery today. Technologies, 1 4
Cherilyn Strader, C. Pearce, N. Oberlies (2011)
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.Journal of natural products, 74 4
G. Cragg, P. Grothaus, D. Newman (2009)
Impact of natural products on developing new anti-cancer agents.Chemical reviews, 109 7
R. Balamurugan, F. Dekker, H. Waldmann (2005)
Design of compound libraries based on natural product scaffolds and protein structure similarity clustering (PSSC).Molecular bioSystems, 1 1
D. Drewry, R. Macarron (2010)
Enhancements of screening collections to address areas of unmet medical need: an industry perspective.Current opinion in chemical biology, 14 3
M. Urabe, M. Yamamoto, R. Takano, S. Tsunamura, S. Miyazaki, K. Watanabe, N. Tsuda (1962)
[Chemotherapy of cancer].Rinsho geka. Journal of clinical surgery, 17
D. Pchejetski, T. Bohler, Leyre Brizuela, L. Sauer, N. Doumerc, M. Golzio, V. Salunkhe, J. Teissié, B. Malavaud, J. Waxman, O. Cuvillier (2010)
FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.Cancer research, 70 21
S. Danishefsky (2010)
On the potential of natural products in the discovery of pharma leads: a case for reassessment.Natural product reports, 27 8
A. Brakhage, V. Schroeckh (2011)
Fungal secondary metabolites - strategies to activate silent gene clusters.Fungal genetics and biology : FG & B, 48 1
J. Niederhuber (1993)
Current therapy in oncology
Jennie Georgsson, Christian Sköld, Milad Botros, G. Lindeberg, F. Nyberg, A. Karlén, A. Hallberg, M. Larhed (2007)
Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.Journal of medicinal chemistry, 50 7
L. Johansson, A. Lindskog, G. Silfversparre, C. Cimander, K. Nielsen, G. Lidén (2005)
Shikimic acid production by a modified strain of E. coli (W3110.shik1) under phosphate‐limited and carbon‐limited conditionsBiotechnology and Bioengineering, 92
I. Jenkins, F. Lacrampe, J. Ripper, L. Alcaraz, P. Le, G. Nikolakopoulos, Priscila Leone, R. White, R. Quinn (2009)
Synthesis of four novel natural product inspired scaffolds for drug discovery.The Journal of organic chemistry, 74 3
M. Abramson (1996)
Complete Drug ReferenceEndocrinologist, 6
A. Graul, L. Sorbera, P. Pina, M. Tell, E. Cruces, E. Rosa, M. Stringer, R. Castañer, L. Revel (2010)
The Year's New Drugs & Biologics - 2009.Drug news & perspectives, 23 1
Jennie Georgsson, Ulrika Rosenström, C. Wallinder, H. Beaudry, Bianca Plouffe, G. Lindeberg, Milad Botros, F. Nyberg, A. Karlén, N. Gallo‐Payet, A. Hallberg (2006)
Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity.Bioorganic & medicinal chemistry, 14 17
Z. Flores-Bustamante, F. Rivera-Orduña, Anahí Martínez-Cárdenas, L. Flores-Cotera (2010)
Microbial paclitaxel: advances and perspectivesThe Journal of Antibiotics, 63
(2002)
Curr Cancer Drug Targ
D. Newman, G. Cragg, K. Snader (2003)
Natural products as sources of new drugs over the period 1981-2002.Journal of natural products, 66 7
(2006)
13:31–37. [PubMed: 16426969] Newman and Cragg Page 16
R. Breinbauer, M. Manger, M. Scheck, H. Waldmann (2002)
Natural product guided compound library development.Current medicinal chemistry, 9 23
A. Staniek, H. Woerdenbag, O. Kayser (2010)
Screening the endophytic flora of Wollemia nobilis for alternative paclitaxel sourcesJournal of Plant Interactions, 5
D. Newman, G. Cragg, S. Holbeck, E. Sausville (2002)
Natural products and derivatives as leads to cell cycle pathway targets in cancer chemotherapy.Current cancer drug targets, 2 4
T. Keller, Arkadius Pichota, Zheng Yin (2006)
A practical view of 'druggability'.Current opinion in chemical biology, 10 4
V. Hruby (2002)
Designing peptide receptor agonists and antagonistsNature Reviews Drug Discovery, 1
M. Krämer, J. Bongaerts, R. Bovenberg, S. Kremer, U. Müller, S. Orf, M. Wubbolts, L. Raeven (2003)
Metabolic engineering for microbial production of shikimic acid.Metabolic engineering, 5 4
Ayub Reayi, P. Arya (2005)
Natural product-like chemical space: search for chemical dissectors of macromolecular interactions.Current opinion in chemical biology, 9 3
K. Urakami, Vincent Zangiacomi, K. Yamaguchi, M. Kusuhara (2010)
Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry.Biomedical research, 31 2
S. Carter, M. Slavik (1977)
Chemotherapy of cancer
R. Kombarov, A. Altieri, Dmitry Genis, Mikhail Kirpichenok, Valeriy Kochubey, N. Rakitina, Zoya Titarenko (2010)
BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discoveryMolecular Diversity, 14
Y. Wan, C. Wallinder, Bianca Plouffe, H. Beaudry, A. Mahalingam, Xiongyu Wu, B. Johansson, M. Holm, Milad Botoros, A. Karlén, A. Pettersson, F. Nyberg, L. Fändriks, N. Gallo‐Payet, A. Hallberg, M. Alterman (2004)
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.Journal of medicinal chemistry, 47 24
K. Jackson, J. Henderson, A. Phillips (2009)
The halichondrins and E7389.Chemical reviews, 109 7
T. Thomas, D. Kavlekar, P. Lokabharathi (2010)
Marine Drugs from Sponge-Microbe Association—A ReviewMarine Drugs, 8
R. Breinbauer, I. Vetter, H. Waldmann (2002)
From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries.Angewandte Chemie, 41 16
D. Newman, G. Cragg, K. Snader (2000)
The influence of natural products upon drug discovery.Natural product reports, 17 3
Aude Violette, S. Fournel, K. Lamour, O. Chaloin, B. Frisch, J. Briand, H. Monteil, G. Guichard (2006)
Mimicking helical antibacterial peptides with nonpeptidic folding oligomers.Chemistry & biology, 13 5
A. Graul (1998)
The year's new drugs.Drug news & perspectives, 13 1
(2009)
Eds.; RSC Publications
Journal of Natural Products – Unpaywall
Published: Feb 8, 2012
Access the full text.
Sign up today, get DeepDyve free for 14 days.